- Home
- BOLT vs TRIB Comparison
BOLT vs TRIB Comparison
Compare BOLT & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- TRIB
- Stock Information
- Founded
- BOLT 2015
- TRIB 1992
- Country
- BOLT United States
- TRIB Ireland
- Employees
- BOLT N/A
- TRIB N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BOLT Health Care
- TRIB Health Care
- Exchange
- BOLT Nasdaq
- TRIB Nasdaq
- Market Cap
- BOLT 16.8M
- TRIB 13.0M
- IPO Year
- BOLT 2021
- TRIB N/A
- Fundamental
- Price
- BOLT $5.87
- TRIB $0.73
- Analyst Decision
- BOLT Buy
- TRIB
- Analyst Count
- BOLT 3
- TRIB 0
- Target Price
- BOLT $50.00
- TRIB N/A
- AVG Volume (30 Days)
- BOLT 25.1K
- TRIB 2.4M
- Earning Date
- BOLT 08-12-2025
- TRIB 08-13-2025
- Dividend Yield
- BOLT N/A
- TRIB N/A
- EPS Growth
- BOLT N/A
- TRIB N/A
- EPS
- BOLT N/A
- TRIB N/A
- Revenue
- BOLT $3,638,000.00
- TRIB $61,555,000.00
- Revenue This Year
- BOLT N/A
- TRIB $13.51
- Revenue Next Year
- BOLT $24.14
- TRIB $13.14
- P/E Ratio
- BOLT N/A
- TRIB N/A
- Revenue Growth
- BOLT N/A
- TRIB 8.31
- 52 Week Low
- BOLT $5.20
- TRIB $0.48
- 52 Week High
- BOLT $15.60
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- BOLT 46.22
- TRIB 56.70
- Support Level
- BOLT $5.52
- TRIB $0.63
- Resistance Level
- BOLT $6.21
- TRIB $0.77
- Average True Range (ATR)
- BOLT 0.33
- TRIB 0.08
- MACD
- BOLT 0.05
- TRIB 0.01
- Stochastic Oscillator
- BOLT 60.00
- TRIB 59.06
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.